Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
P/E Ratio HistoryFair Value
Percentile Rank43
3Y CAGR+0.2%
5Y CAGR+3.9%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+0.2%/yr
vs +0.4%/yr prior
5Y CAGR
+3.9%/yr
Recent deceleration
Acceleration
-0.2pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 17.92 | +2.9% |
| 2024 | 17.42 | -26.5% |
| 2023 | 23.70 | +33.1% |
| 2022 | 17.81 | +115.5% |
| 2021 | 8.27 | -44.1% |
| 2020 | 14.80 | -23.6% |
| 2019 | 19.38 | +10.5% |
| 2018 | 17.54 | -51.8% |
| 2017 | 36.36 | -23.7% |
| 2016 | 47.65 | - |